Form 8-K - Current report:
SEC Accession No. 0001493152-17-006919
Filing Date
2017-06-20
Accepted
2017-06-20 17:26:45
Documents
7
Period of Report
2017-06-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 39225
2 ex10-1.htm EX-10.1 87863
3 ex10-2.htm EX-10.2 92508
4 ex10-3.htm EX-10.3 124824
5 ex10-4.htm EX-10.4 44168
6 ex99-1.htm EX-99.1 18909
7 ex99-1_001.jpg GRAPHIC 8093
  Complete submission text file 0001493152-17-006919.txt   420136
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 17921583
SIC: 2834 Pharmaceutical Preparations